Decoy Therapeutics Inc. Shareholders' Equity
Decoy Therapeutics Inc. (DCOY) had Shareholders' Equity of $4.32 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-12
- 2026-06-30: Stockholders' Equity Attributable to Parent $4.32M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $3.88M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $5.89M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $4.25M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $4.32M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $3.88M 10-Q · filed 2026-08-12 | |
| 2025-12-31 | $5.89M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $4.25M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | -$829.72K 10-Q · filed 2026-08-12 | |
| 2025-03-31 | $61.87K 10-Q · filed 2026-08-12 | |
| 2024-12-31 | $1.51M 10-Q · filed 2026-08-12 | |
| 2024-09-30 | $2.92M 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $2.38M 10-Q · filed 2025-11-14 | |
| 2024-03-31 | $3.65M 10-Q · filed 2025-11-14 | |
| 2023-12-31 | $5.29M 10-K · filed 2026-03-31 | |
| 2023-09-30 | $6.08M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $8.41M 10-Q · filed 2024-11-14 | |
| 2023-03-31 | $5.56M 10-Q · filed 2024-11-14 | |
| 2022-12-31 | $10.38M 10-K · filed 2025-03-21 | |
| 2022-09-30 | $16.61M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $30.88M 10-Q · filed 2023-11-09 | |
| 2022-03-31 | $33.42M 10-Q · filed 2023-11-09 | |
| 2021-12-31 | $38.72M 10-K · filed 2024-03-22 | |
| 2021-09-30 | $42.65M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $45.85M 10-Q · filed 2022-11-10 | |
| 2021-03-31 | $48.78M 10-Q · filed 2022-11-10 | |
| 2020-12-31 | $22.16M 10-K · filed 2023-03-27 | |
| 2020-09-30 | $20.61M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $16.85M 10-Q · filed 2021-11-04 | |
| 2020-03-31 | $18.00M 10-Q · filed 2021-11-04 | |
| 2019-12-31 | $10.58M 10-K · filed 2022-03-25 | |
| 2019-09-30 | $9.74M 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $732.91K 10-Q · filed 2020-11-12 | $6.10M 10-Q · filed 2019-07-17 |
| 2019-03-31 | $1.73M 10-Q · filed 2020-11-12 | $7.27M 10-Q · filed 2019-05-01 |
| 2018-12-31 | -$1.27M 10-K · filed 2021-03-18 | $9.28M 10-K · filed 2019-03-06 |
| 2018-09-30 | -$1.49M 10-Q · filed 2019-11-12 | $11.05M 10-Q · filed 2018-11-05 |
| 2018-06-30 | -$1.18M 10-Q · filed 2019-11-12 | $13.41M 10-Q · filed 2018-08-01 |
| 2018-03-31 | -$3.32M 10-Q · filed 2019-11-12 | $21.89M 10-Q · filed 2018-05-02 |
| 2017-12-31 | -$2.90M 10-K · filed 2020-03-23 | $29.11M 10-K · filed 2018-03-07 |
| 2017-09-30 | $36.18M 10-Q · filed 2017-11-06 | |
| 2017-06-30 | $44.50M 10-Q · filed 2017-08-02 | |
| 2017-03-31 | $52.23M 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $59.32M 10-K · filed 2019-03-06 | |
| 2016-09-30 | $66.03M 10-Q · filed 2016-11-02 | |
| 2016-06-30 | $74.82M 10-Q · filed 2016-08-03 | |
| 2016-03-31 | $84.17M 10-Q · filed 2016-05-04 | |
| 2015-12-31 | $92.19M 10-K · filed 2019-03-06 | |
| 2015-09-30 | $98.00M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $104.65M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $110.08M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | -$6.54M 10-K · filed 2018-03-07 | |
| 2014-02-26 | $0.00 10-K · filed 2017-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |